Roche Aktie

311,30EUR
-5,35EUR
-1,69%
19:21:03
317,55CHF
-5,00CHF
-1,55%
17:30:36

WKN: 855167 / ISIN: CH0012032048

  Kaufen  
Verkaufen
oder
Werbung

Roche Aktien News

31.05.22FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy (SMA) (GlobeNewswire)
08.06.22European Commission approves Roche’s first-in-class bispecific antibody Lunsumio for people with relapsed or refractory follicular lymphoma (GlobeNewswire)
09.06.22European Commission approves Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer (GlobeNewswire)
09.06.22U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib) (GlobeNewswire)
10.06.22Roche announces positive data from broad blood cancer portfolio at European Hematology Association Annual Meeting (GlobeNewswire)
16.06.22Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease (GlobeNewswire)
16.06.22Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options (GlobeNewswire)
15.06.22Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19 (GlobeNewswire)
02.06.22
Dow Jones Newswires: Repare Therapeutics shares rise 18% after news of Roche deal (MarketWatch)
02.06.22
Roche, Repare's licensing deal includes milestone payments worth up to $1.2 billion (Market Watch)
02.06.22
Repare (RPTX) Up 20% on Deal With Roche for Solid Tumor Drug (Zacks)
03.06.22
Top Research Reports for Roche, Philip Morris & HSBC (Zacks)
06.06.22
The Zacks Analyst Blog Highlights Roche Holding, Philip Morris, HSBC, AMD, and Lockheed Martin (Zacks)
31.05.22
The Zacks Analyst Blog Highlights AstraZeneca, Merck, Roche, J&J, and Pfizer (Zacks)
09.06.22
Roche (RHHBY) Gets EU Nod for Lunsumio, Tecentriq Label Expansion (Zacks)
16.06.22
Roche (RHHBY) Alzheimer's Disease Drug Data Disappoints (Zacks)
17.06.22
Roche Alzheimer's Candidate Failure Hurts Lilly, Biogen (Zacks)
20.06.22
The Zacks Analyst Blog Highlights Lilly, Merck, Roche, Pfizer and Moderna (Zacks)
06:00 Uhr
F. Hoffmann-La Roche Ltd : Roche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnostics (Investegate)
16.06.22
F. Hoffmann-La Roche Ltd : Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease (Investegate)
16.06.22
F. Hoffmann-La Roche Ltd : Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options (Investegate)
15.06.22
F. Hoffmann-La Roche Ltd : Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19 (Investegate)
10.06.22
F. Hoffmann-La Roche Ltd : Roche announces positive data from broad blood cancer portfolio at European Hematology Association Annual Meeting (Investegate)
09.06.22
F. Hoffmann-La Roche Ltd : European Commission approves Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer (Investegate)
09.06.22
F. Hoffmann-La Roche Ltd : U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib) (Investegate)
08.06.22
F. Hoffmann-La Roche Ltd : European Commission approves Roche’s first-in-class bispecific antibody Lunsumio for people with relapsed or refractory follicular lymphoma (Investegate)
31.05.22
F. Hoffmann-La Roche Ltd : FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy (SMA) (Investegate)

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln